BANDUNG, INDONESIA, Oct 2, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export its novel Oral Polio Vaccine type 2 (nOPV2) having secured a purchase contract with the United Nations Children’s Fund (UNICEF) for 2022 & 23. Under the contract, Bio Farma will... » read more
BANDUNG, INDONESIA, Sep 12, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, its Covid-19 vaccines brand, including primary series vaccines, booster vaccines and vaccines for children, in development since November 2021. IndoVac Covid-19 vaccine in production at... » read more
Bandung, W Java, Indonesia, Sep 9, 2022 – (ACN Newswire via SEAPRWire.com) – PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. IndoVac Covid-19 vaccine in production at PT Bio Farma’s facilities near... » read more
OSLO, Norway/ TOKYO, Japan, Apr 8, 2022 – (JCN Newswire via SEAPRWire.com) – CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation (NEC: TSE: 6701) today announced the latest funding award under its US$200m programme to advance the development of vaccines that provide broad protection against SARS-CoV-2 variants and other betacoronaviruses(1). CEPI will provide... » read more
HONG KONG, Apr 1, 2022 – (ACN Newswire via SEAPRWire.com) – On March 31, the China-based novel vaccines company – Jiangsu Recbio Technology Co., Ltd. (“Recbio” or the “Company”, Stock Code: 2179.HK) went public and was officially listed on the Hong Kong Stock Exchange. Assuming the Over-allotment option is not exercised, 30,854,500 H shares were... » read more
Cambridge, MA, Feb 16, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its commercial network across Asia with the addition of four new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong. This expansion comes as the Company... » read more
SINGAPORE – Three different Covid-19 messenger RNA vaccines which may have reduced side effects when administered are being developed with Singapore’s involvement in their clinical trials. Developed by United States-firm Arcturus Therapeutics, the three vaccine candidates can be given at a much lower dose than the mRNA vaccines now available – such as those by... » read more
SINGAPORE – Singapore is set to receive a batch of Covid-19 vaccines called Comirnaty, as the Republic ramps up supplies to get as many people inoculated as possible. In a statement on Wednesday (June 23), the Ministry of Health (MOH) said that the vaccines are the same as the Pfizer-BioNTech vaccines that are now used... » read more
SINGAPORE – Pregnant and breastfeeding women should get vaccinated to protect themselves and their babies from Covid-19, as real-world data has shown that this is not only safe but is also beneficial to both mother and child, said specialists here. With the emergence of new Covid-19 variants and a resurgence of community-transmitted cases, there is... » read more
SINGAPORE – The two vaccines Singapore is using will protect significantly, but not absolutely, against all current variants of the coronavirus that causes Covid-19, say experts. To what extent, however, is where they do not agree. The Ministry of Health said last week that all three Covid-19 variants of concern (VOCs) – strains that could... » read more
SINGAPORE – There has been no uptick in heart attacks or strokes among vaccinated people, and no evidence that the Covid-19 vaccines used here can directly cause them, the Health Sciences Authority (HSA) said on Thursday (May 6). “A greater frequency of heart attacks and strokes has not been observed in vaccinated persons locally and... » read more
SINGAPORE – Mixing Covid-19 vaccines is possible and could even be beneficial at inciting a more robust immune response to the coronavirus. But experts warn that more studies are needed to ascertain the effectiveness of such a regime, and to determine that doing so will not produce any side effects. The experts were responding to... » read more
Toyota City, Japan, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – Toyota Tsusho Corporation, Toyota Motor Corporation, and B Medical Systems S.a r.l. announced today that the vehicle with a dedicated refrigerator for transporting vaccines at the appropriate temperatures developed jointly by the three companies has obtained Performance, Quality and Safety (PQS) prequalification for... » read more
SINGAPORE – Singapore will use Covid-19 vaccines no matter where they are made, as long as they are safe and effective, said Prime Minister Lee Hsien Loong in an interview with the BBC broadcast on Sunday (March 14). “We will use vaccines from any source. Vaccines do not carry a nationality. Is it good or... » read more
SINGAPORE – Singapore is in discussions with the major suppliers of coronavirus vaccines and could possibly play a role in distributing them, said Trade and Industry Minister Chan Chun Sing on Monday (Dec 21). Singapore’s role would not be in the production itself, added Mr Chan, as he addressed a question on the Republic’s possible... » read more
SINGAPORE – Singapore Airlines (SIA) will prioritise the mass shipments of Covid-19 vaccines into and through Singapore when they are available. The carrier will also conduct test flights to trial vaccine transportation “soon”, similar to what airlines in Belgium and United States are doing. “SIA will make available cargo space on its flights and accord... » read more
SINGAPORE – The Republic will contribute US$5 million (S$6.6 million) to a global initiative to ensure sufficient production of Covid-19 vaccines and access for poorer nations. The Advance Market Commitment (AMC) is a mechanism under the Covid-19 Vaccine Global Access (Covax) Facility. It aims to incentivise manufacturers to produce sufficient quantities of Covid-19 vaccines, and... » read more